Log in to search using one of your social media accounts:

 

FDA Drug Safety Communication: FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic liver disease
The Food and Drug Administration (FDA) is warning that the liver disease medicine Ocaliva (obeticholic acid) is being incorrectly dosed in some patients with moderate to severe decreases in liver function, resulting in an increased risk of serious liver injury and death. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 21, 2017 Category: Drugs & Pharmacology Source Type: news

Why is the flu vaccine so mediocre?
(Source: ScienceNOW)
Source: ScienceNOW - September 21, 2017 Category: Science Authors: Cohen, J. Tags: Immunology, Medicine, Diseases, Pharmacology, Toxicology, Virology In Depth Source Type: news

RPS Position statement on the role of registered technicians to supervise the sale and supply of medicines
RPS members have contacted the Society recently wanting to understand our view on the role of registered technicians to supervise the sale and supply of medicines. We understand that the Society must (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 20, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning
[8-31-2016] A U.S. Food and Drug Administration (FDA) review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects, including slowed or difficult breathing and deaths. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 20, 2017 Category: Drugs & Pharmacology Source Type: news

Medical Device Alert: All Accu-Chek Insight insulin pumps- risk of alarm failure
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 20, 2017 Category: Drugs & Pharmacology Source Type: news

Spectazole (Econazole Nitrate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 20, 2017 Category: Drugs & Pharmacology Source Type: news

Avagard Lotion (Avagard Lotion Instant Hand Antiseptic With Moisturizers) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 20, 2017 Category: Drugs & Pharmacology Source Type: news

Fentanyl Buccal (Fentanyl Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 20, 2017 Category: Drugs & Pharmacology Source Type: news

Avagard Foam (Avagard Foam Instant Hand Antiseptic With Moisturizers) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 20, 2017 Category: Drugs & Pharmacology Source Type: news

Radavirsen performs well in early influenza trial
(Wiley) A phase 1 clinical trial published in the British Journal of Clinical Pharmacology found that radavirsen--an antisense oligomer that inhibits the production of certain influenza proteins -- is safe and well-tolerated in healthy individuals. Additional studies on radavirsen's potential as a treatment for influenza are warranted. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 20, 2017 Category: International Medicine & Public Health Source Type: news

Folic Acid Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

Aminocaproic Acid Injection, USP (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

Dermatologic and Ophthalmic Drugs Advisory Committee Roster
This page contains the DODAC roster, which lists the current members and the current number of vacancies for the committee. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks
Based on our additional review, the U.S. Food and Drug Administration (FDA) is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system (CNS). The combined use of these drugs increases the risk of serious side effects; however, the harm caused by untreated opioid addiction usually outweighs these risks. Careful medication management by health care professionals can reduce these risks. We are requiring this information to be added to the buprenorphine and methadone drug labels along with detai...
Source: FDA Center for Drug Evaluation and Research - What's New - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

Flomax and Viagra for BPH Treatment
Title: Flomax and Viagra for BPH TreatmentCategory: MedicationsCreated: 9/18/2017 12:00:00 AMLast Editorial Review: 9/19/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

Flomax and Viagra for BPH
Title: Flomax and Viagra for BPHCategory: MedicationsCreated: 9/18/2017 12:00:00 AMLast Editorial Review: 9/19/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

Optinose Announces FDA Approval of Xhance (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps
YARDLEY, Pa.--(BUSINESS WIRE)-- September 18, 2017 -- Optinose, an ENT / Allergy specialty pharmaceutical company, announced today that the U.S. Food& Drug Administration (FDA) approved the Company ’s New Drug Application (NDA) for Xhance... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

HBV Reactivation After Treatment With DAAs for HCV HBV Reactivation After Treatment With DAAs for HCV
HBV reactivation has been observed in patients after successful HCV eradication with interferon-based therapies. Does similar reactivation occur after treatment with direct-acting antivirals?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Grants Fast Track Designation for Amicus Therapeutics' Migalastat for Treatment of Fabry Disease
CRANBURY, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the oral precision medicine migalastat for the treatment of... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 19, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD
London UK – 18 September 2017 -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Symbiomix Therapeutics ’ Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women
NEWARK, N.J.--(BUSINESS WIRE) September 18, 2017 --Symbiomix Therapeutics today announced the U.S. Food and Drug Administration (FDA) has approved Solosec (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women.... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Q4B Annex 8: Sterility Test General Chapter
International Council on Harmonisation - Quality (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Q4B Annex 9: Tablet Friability General Chapter
International Council on Harmonisation - Quality (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Q4B Annex 5: Disintegration Test General Chapter
International Council on Harmonisation - Quality (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Norditropin (Somatropin Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Flomax vs. Viagra for BPH
Title: Flomax vs. Viagra for BPHCategory: MedicationsCreated: 9/18/2017 12:00:00 AMLast Editorial Review: 9/18/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Camurus Announces that FDA Grants Priority Review of NDA for Weekly and Monthly CAM2038 Buprenorphine Depots for Treatment of Opioid Use Disorder
Lund, Sweden – 18 September 2017 — Camurus (NASDAQ STO: CAMX) announces that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for weekly and monthly CAM2038 buprenorphine depots for the treatment of adults... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves New Indication for Ipsen ’s Somatuline Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Paris (France) September 18, 2017 -- Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental indication for Somatuline Depot (lanreotide) Injection 120 mg for the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Neos Therapeutics Receives U.S. FDA Approval of Adzenys ER (amphetamine) Extended-Release Oral Suspension for ADHD
DALLAS and FORT WORTH, Texas, Sept. 15, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release products using its proprietary... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 15, 2017 Category: Drugs & Pharmacology Source Type: news

Neal Patel debates access to emergency contraception on ITV News
Emergency contraception has been high on the news agenda recently due to a campaign by the BPAS, focusing on its price and questioning the need for consultation. The latest news that the morning after (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 15, 2017 Category: Drugs & Pharmacology Source Type: news

RPS endorses the prescribing support for junior doctors
The Royal Pharmaceutical Society has contributed to the publication of the new prescribing support guidefor junior doctors, published by the Royal College of Physicians. The report recognises that pha (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 15, 2017 Category: Drugs & Pharmacology Source Type: news

Nityr (Nitisinone Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 15, 2017 Category: Drugs & Pharmacology Source Type: news

Do I need Rehab to Quit Percocet?
Title: Do I need Rehab to Quit Percocet?Category: Doctor's& Expert's views on SymptomsCreated: 9/15/2017 12:00:00 AMLast Editorial Review: 9/15/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 15, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves New indication for Briviact (brivaracetam) as Monotherapy Treatment of Partial-Onset Seizures in Adults
Atlanta, Georgia (U.S.)& Brussels (Belgium), 15 September, 2017 – 0700 (CEST): UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Briviact (brivaracetam) CV as... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 15, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Mvasi (bevacizumab-awwb), a Biosimilar to Avastin
September 14, 2017 -- The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma
September 14, 2017 -- The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Sodium Phosphate Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

◦Sodium Phosphate Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Professor Ian Bates receives the RPS Charter Award
Professor Iain Bates, Professor of Pharmacy Education at UCL and Professor of Integrated Care Education, Whittington Health NHS Trust, a Fellow of the Royal Pharmaceutical Society, has been given the (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Update your LPF and group network preferences
Stay in the know by ensuring your LPF& network preferences are up-to-date From talking to you, we have learnt that it has beendifficult to stay in touch with your local groups and one of the rea (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Marlissa (Levonorgestrel and Ethinyl Estradiol Tablets USP) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Pimtrea (Desogestrel and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Gildagia (Norethindrone and Ethinyl Estradiol Tablets, USP) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Dilaudid vs. Oxycodone
Title: Dilaudid vs. OxycodoneCategory: MedicationsCreated: 9/14/2017 12:00:00 AMLast Editorial Review: 9/14/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Percocet Vs. Hydrocodone
Title: Percocet Vs. HydrocodoneCategory: MedicationsCreated: 9/14/2017 12:00:00 AMLast Editorial Review: 9/14/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Oxycodone vs. Codeine
Title: Oxycodone vs. CodeineCategory: MedicationsCreated: 9/14/2017 12:00:00 AMLast Editorial Review: 9/14/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

CSL Behring Announces FDA Approval of Privigen [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults
KING OF PRUSSIA, Pa. — 14 September 2017 -- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Sunovion ’s Aptiom (eslicarbazepine acetate) Receives FDA Approval for Expanded Indication to Treat Partial-Onset Seizures in Children and Adolescents 4 Years of Age and Older
MARLBOROUGH, Mass.--(BUSINESS WIRE)--September 14, 2017 Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) to expand the indication for its... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Sponsored Collection | SPReading the word: The importance of binding kinetics
(Source: ScienceNOW)
Source: ScienceNOW - September 14, 2017 Category: Science Tags: Botany, Cell Biology, Medicine, Diseases, Neuroscience, Pharmacology, Toxicology opms-sups Source Type: news

Triamcinolone Acetonide Cream (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 13, 2017 Category: Drugs & Pharmacology Source Type: news